Navigation Links
Caliper Life Sciences to Webcast Investor Session of Open House
Date:6/3/2010

HOPKINTON, Mass., June 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that it will hold a Customer Owner's Group (COG) meeting to be held June 9 and 10, 2010 at Caliper's Hopkinton headquarters.  The company will webcast a separate Investor Breakout Session from 2:00 - 3:00 p.m. EDT on Thursday, June 10.

The investor portion of the conference will feature a presentation by Kevin Hrusovsky, President and CEO, who will outline Caliper's strategic priorities and the future direction of Caliper's technologies and services, followed by Q&A with a management panel.  The Customer Open House sessions will include presentations from over two dozen of the company's customers highlighting their innovative uses of Caliper's technologies in drug discovery and development and molecular biology.  The full agenda can be viewed at http://www.caliperls.com//products/cog2010.php.

Attendance at the event is by invitation only due to limited seating availability.  Persons interested in reserving a seat should contact Cathy Portanova at cathy.portanova@caliperls.com.  

To participate in the call, please dial 888.679.8040 five to ten minutes prior to the call and use the participant passcode of 56829909. International callers may access the call by dialing 617.213.4851 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=P9AWLR9AW.  A live webcast of the call can also be accessed on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page.

Telephone replays of the presentation will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from June 10 through June 17, dial 888.286.8010 and use the participant passcode of 93916636. International callers can access the playback by dialing 617.801.6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
8. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference
9. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
10. Caliper Life Sciences to Present at Deutsche Bank 2008 Small and Mid Cap Growth Conference
11. Caliper Life Sciences Fourth Quarter 2007 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... ... 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), a ... announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s ... commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio and ...
(Date:2/22/2017)... 22, 2017 Origin (Origin Agritech, LLC, a subsidiary of ... provider, and Arcadia (Arcadia Biosciences, Inc., NASDAQ: ... commercializes agricultural productivity traits and nutritional products, today announced their collaboration ... developed in China to the ... ...
Breaking Biology Technology:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):